ʻO SARS-CoV-2 Antigen Rapid Test (Colloidal Gold)

Manaʻo ʻia ʻo SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) no ka ʻike qualitative o SARS-CoV-2 Antigen (Nucleocapsid protein) i loko o nā laʻana kohu kanaka i vitro.

Hoʻohana ʻia i nā hiʻohiʻona aʻe:

1. ka nānā ʻana i ka heluna kanaka, e like me ka haukapila, kahua mokulele, ke kahua, kaiāulu, etc.

2. ka nānā mau ʻana i ka wā pōkole.

* Mea hoʻoheheʻe ʻia i ka ihu o mua, ʻaʻole hoʻomake

* Maʻalahi loa e hoʻohana

* Maʻalahi, ʻaʻohe mea hana pono

* Ka wikiwiki, nā hopena i loko o 15-20 mau minuke

* Maikaʻi ke kumu kūʻai

ʻO SARS-CoV-2 Antigen Rapid Test (Colloidal Gold)

Hoʻokumu ʻia ka ʻāpana virus SARS-CoV-2 i ʻelima mau ʻāpana: kahi kaulahao gene RNA a me ʻehā mau protein. He Spike Protein (S) ka papa waho loa o ka ʻāpana, a ʻo ka Envelope viral ma lalo o ka Spike i haku ʻia me Envelope Protein (E) a me Membrane Protein (M). ʻO ke kumu i loko o ka envelopp he hale i hoʻopili ʻia helical i haku ʻia me nā kaulahao gene RNA a me nā protein Nucleocapsid (N). Ke hoʻohana nei i ke kumu o ka hoʻopaʻa ʻana o ka antigen a me ka antibody, hiki ke ʻike ʻia ka hele ʻana o SARS-CoV-2 antigen (Nucleocapsid protein) e ka antibody.

Nā pōmaikaʻi ma luna o Elisa a me PCR

Ua hoʻokumu ʻia ka hana o ka SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) me 859 specimens i hōʻiliʻili ʻia mai nā mea maʻi maʻi maʻi i manaʻo ʻia he COVID-19. Ua hōʻiliʻili ʻia a hoʻāʻo ʻia e like me nā koi o nā ʻōkuhi no ka hoʻohana ʻana. ʻO ka mālama ʻana, ka lawe ʻana a me ka ʻike ʻana i nā laʻana ma hope o ka hōʻiliʻili ʻana i hoʻokō i nā koi kūpono o nā ʻōkuhi no ka hoʻohana. I ka manawa like, ua ʻike ʻia ʻo SARS-CoV-2 e ka nucleic acid detection reagent.

ʻO ka hōʻuluʻulu ʻana o ka hana maʻi o ka SARS-CoV-2 Antigen Rapid Test (Colloidal Gold)

PPA: 95.91% (C.I. 93.25%~97.55%)

NPA: 100.00% (C.I. 99.26%~100.00%)

OPA: 98.37% (C.I. 97.28%~99.03%)

ʻO mākou, ka mea hana, me kēia, ke haʻi aku nei nā huahana e like me ka mea i ʻōlelo ʻia ma luna nei e hoʻokō i nā ʻōlelo pili o ka European Directive 98/79/EC ma in vitro Diagnostic Medical Devices. ʻO nā palapala ʻenehana kākoʻo āpau e hōʻike ana i ka hoʻokō ʻia e mālama ʻia e ka mea hana a hiki ke loaʻa e ka Lunamakaʻāinana Manaʻo ma ʻEulopa.

ʻO ka hōʻoia ʻana o ka hui

ʻIkepili Hui

Hōʻikeʻike Hui

Q1. He hale hana ʻoe a ʻoihana kālepa paha?

A: ʻO ʻelua. Ua noho mākou ma kēia kahua no nā makahiki ʻoi aku ma mua o 7. Me nā huahana maikaʻi loa a me ke kumukūʻai hoʻokūkū, manaʻolana mākou e hoʻomohala i ka ʻoihana pono like me kā mākou mea kūʻai aku ma ka honua holoʻokoʻa.

Q2. He aha kāu mau ʻōlelo uku?

A: T / T, L / C, D / A, D / P a pēlā aku.

Q3. He aha kāu mau ʻōlelo hoʻouna?

A: EXW, FOB, CFR, CIF, DDU a pēlā aku.

Q4. Pehea e pili ana i ka manawa hāʻawi o SARS-CoV-2 Antigen Rapid Test (Colloidal Gold)?

A: ʻO ka maʻamau, e lawe ʻia ʻo 15 a 30 mau lā ma hope o ka loaʻa ʻana o ka waihona ʻO ka manawa hoʻopuka kikoʻī e pili ana i nā mea a me ka nui o kāu kauoha.

Q5. Hiki iā ʻoe ke hoʻonohonoho i ka hana e like me nā laʻana?

A: ʻAe, hiki iā mākou ke hana e kāu mau hiʻohiʻona a i ʻole nā ​​kiʻi ʻenehana.

Q6. He aha kāu kumu hoʻohālike?

A: Inā liʻiliʻi ka nui, e noa nā laʻana, akā pono nā mea kūʻai aku e uku i ke kumukūʻai ʻelele.

Q7. Ke ho'āʻo neiʻoe i kāu mau waiwai a pau ma mua o ka laweʻana?

A: ʻAe, loaʻa iā mākou he 100% hōʻike ma mua o ka lawe ʻana.

Q8. Pehea ʻoe e hana ai i kā mākou ʻoihana i ka pilina lōʻihi a maikaʻi?

A: Mālama mākou i ka maikaʻi a me ke kumukūʻai hoʻokūkū e hōʻoia i ka pōmaikaʻi o kā mākou mea kūʻai; a mahalo mākou i kēlā me kēia mea kūʻai aku ma ke ʻano he hoaaloha a ʻoiaʻiʻo mākou e hana ʻoihana a hoʻolauna pū me lākou.